January 7, 2020

Price hikes for hundreds of medications

U.S. drug companies have started the new year by raising the prices of hundreds of medications.

Just a few days into 2020, the prices of 411 drugs increased an average of 5 percent, according to GoodRx. Of those drugs, 407 are brand-name products and four are generics, CBS News reported.

The largest increase was a more than 13 percent rise in the list price of Neos Therapeutics' Cotempla XR, a stimulant used to treat attention-deficit/hyperactivity disorder and narcolepsy. Other commonly prescribed drugs with price increases include Eliquis (6 percent), often prescribed to prevent blood clots, and Humira (7.4 percent), used to treat inflammation in patients with autoimmune disease, CBS News reported.

More drugs are likely to see price hikes in the coming weeks, experts added.

More information: CBS News Article

Citation: Price hikes for hundreds of medications (2020, January 7) retrieved 2 May 2024 from https://medicalxpress.com/news/2020-01-price-hikes-hundreds-medications.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Rising drug costs can be traced to price hikes for older, brand-name medicine

2 shares

Feedback to editors

New study supports psilocybin's potential as an antidepressant

7 hours ago

Global study reveals stark differences between females and males in disease burden causes

7 hours ago

Researcher discusses mechanism behind a birth defect affecting brain size

9 hours ago

Study indicates that cancer patients gain important benefits from genome-matched treatments

9 hours ago

Machine learning tool identifies rare, undiagnosed immune disorders through patients' electronic health records

10 hours ago

New technique improves T cell-based immunotherapies for solid tumors

10 hours ago

Unraveling the roles of non-coding DNA explains childhood cancer's resistance to chemotherapy

11 hours ago

Conscious memories of childhood maltreatment strongly associated with psychopathology

11 hours ago

Study finds private equity expanding to mental health facilities

11 hours ago

Organ transplant drug may slow Alzheimer's disease progression

11 hours ago

Load comments (0)

Price hikes for hundreds of medications

New study supports psilocybin's potential as an antidepressant

Global study reveals stark differences between females and males in disease burden causes

Researcher discusses mechanism behind a birth defect affecting brain size

Study indicates that cancer patients gain important benefits from genome-matched treatments

Machine learning tool identifies rare, undiagnosed immune disorders through patients' electronic health records

New technique improves T cell-based immunotherapies for solid tumors

Unraveling the roles of non-coding DNA explains childhood cancer's resistance to chemotherapy

Conscious memories of childhood maltreatment strongly associated with psychopathology

Study finds private equity expanding to mental health facilities

Organ transplant drug may slow Alzheimer's disease progression

Rising drug costs can be traced to price hikes for older, brand-name medicine

Rising drug prices linked to older products, not just newer, better medications

Brand-name drug prices rising at slower pace, lower amounts

Brand-brand competition is unlikely to reduce list prices of medicines

Big box pharmacies offer lowest cash prices for generic drugs

Do price spikes on some generic drugs indicate problems in the market?

First effective treatment found for spitting cobra snakebite

Organ transplant drug may slow Alzheimer's disease progression

Study finds private equity expanding to mental health facilities

A better COVID treatment for the immunocompromised? Researchers create a non-toxic potential alternative to Paxlovid

Patients diagnosed with cancer in prison more likely to die from the disease, research shows

Early gestational diabetes treatment shown to reduce birth complications, health costs for those at higher risk

Phys.org

Tech Xplore

Science X

Price hikes for hundreds of medications

New study supports psilocybin's potential as an antidepressant

Global study reveals stark differences between females and males in disease burden causes

Researcher discusses mechanism behind a birth defect affecting brain size

Study indicates that cancer patients gain important benefits from genome-matched treatments

Machine learning tool identifies rare, undiagnosed immune disorders through patients' electronic health records

New technique improves T cell-based immunotherapies for solid tumors

Unraveling the roles of non-coding DNA explains childhood cancer's resistance to chemotherapy

Conscious memories of childhood maltreatment strongly associated with psychopathology

Study finds private equity expanding to mental health facilities

Organ transplant drug may slow Alzheimer's disease progression

Related Stories

Rising drug costs can be traced to price hikes for older, brand-name medicine

Rising drug prices linked to older products, not just newer, better medications

Brand-name drug prices rising at slower pace, lower amounts

Brand-brand competition is unlikely to reduce list prices of medicines

Big box pharmacies offer lowest cash prices for generic drugs

Do price spikes on some generic drugs indicate problems in the market?

Recommended for you

First effective treatment found for spitting cobra snakebite

Organ transplant drug may slow Alzheimer's disease progression

Study finds private equity expanding to mental health facilities

A better COVID treatment for the immunocompromised? Researchers create a non-toxic potential alternative to Paxlovid

Patients diagnosed with cancer in prison more likely to die from the disease, research shows

Early gestational diabetes treatment shown to reduce birth complications, health costs for those at higher risk

Newsletter sign up

Donate and enjoy an ad-free experience